GRTX vs. JAGX, OMGA, MTVA, NKGN, LIPO, AYTU, ALBT, AIM, SNOA, and CPHI
Should you be buying Galera Therapeutics stock or one of its competitors? The main competitors of Galera Therapeutics include Jaguar Health (JAGX), Omega Therapeutics (OMGA), MetaVia (MTVA), NKGen Biotech (NKGN), Lipella Pharmaceuticals (LIPO), Aytu BioPharma (AYTU), Avalon GloboCare (ALBT), AIM ImmunoTech (AIM), Sonoma Pharmaceuticals (SNOA), and China Pharma (CPHI). These companies are all part of the "pharmaceutical products" industry.
Galera Therapeutics vs.
Galera Therapeutics (NASDAQ:GRTX) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.
50.8% of Galera Therapeutics shares are held by institutional investors. Comparatively, 12.0% of Jaguar Health shares are held by institutional investors. 12.9% of Galera Therapeutics shares are held by company insiders. Comparatively, 0.4% of Jaguar Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Jaguar Health received 1785 more outperform votes than Galera Therapeutics when rated by MarketBeat users. Likewise, 88.65% of users gave Jaguar Health an outperform vote while only 54.35% of users gave Galera Therapeutics an outperform vote.
In the previous week, Jaguar Health had 3 more articles in the media than Galera Therapeutics. MarketBeat recorded 3 mentions for Jaguar Health and 0 mentions for Galera Therapeutics. Jaguar Health's average media sentiment score of 0.31 beat Galera Therapeutics' score of 0.00 indicating that Jaguar Health is being referred to more favorably in the news media.
Galera Therapeutics has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. Galera Therapeutics' return on equity of 0.00% beat Jaguar Health's return on equity.
Galera Therapeutics has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
Jaguar Health has higher revenue and earnings than Galera Therapeutics.
Summary
Jaguar Health beats Galera Therapeutics on 7 of the 12 factors compared between the two stocks.
Get Galera Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Galera Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:GRTX) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy GRTX Stock Free GRTX Stock Alerts